Body Surface Area Calculator

Understanding the Body Surface Area Calculator

A body surface area calculator computes BSA from height and weight using the Du Bois formula. It's a genuinely clinical measure, used for chemotherapy dosing, cardiac index, and burn assessment, and it's one of the few calculations where the underlying convention is itself actively debated in the literature.

How it actually works

Enter weight and height. The calculator applies the Du Bois formula, multiplying a constant by weight in kilograms raised to the power 0.425 and height in centimetres raised to 0.725. A 170-pound person at 5 feet 8 inches has a BSA of about 1.91 square metres.

The deeper context most people miss

BSA is used in medicine because several physiological variables scale more closely with surface area than with body weight, including cardiac output, glomerular filtration rate, and metabolic rate. That relationship is the justification for BSA-based dosing, and how well it actually holds for drug clearance is precisely what has been questioned.

Where the formula came from and how good it is

The Du Bois formula was published in 1916, derived from measurements of just nine subjects whose surface area was determined by wrapping them in paper moulds and measuring the material. That sample size sounds alarmingly small by modern standards, and the formula has nonetheless proven remarkably durable, remaining the most widely used more than a century later. Several alternatives exist and generally agree within a few percent for adults of typical build: Mosteller, published in 1987, is popular precisely because it is simple enough to compute mentally, being the square root of height in centimetres multiplied by weight in kilograms divided by 3600. Haycock, Gehan and George, and Boyd are others in common use. Where the formulas diverge more noticeably is at the extremes, particularly in obesity, where Du Bois has been shown to underestimate compared with more recent equations derived from larger and more varied samples. Since chemotherapy doses are calculated from BSA, that divergence has clinical consequences, and different institutions using different formulas can produce different doses for the same patient. Some centres cap BSA at a maximum value, commonly 2.0 square metres, when dosing certain agents in patients with obesity, a practice that has itself been questioned since capping may underdose patients who would tolerate and benefit from the full calculated dose. Guidelines have moved toward using actual body weight without capping for most chemotherapy agents, following evidence that capping was associated with worse outcomes.

A worked example: why chemotherapy dosing uses BSA at all

A drug dosed at 100 milligrams per square metre would be given as 191 milligrams to someone with a BSA of 1.91. The historical rationale was sound in principle: BSA correlates with metabolic rate and with several physiological parameters affecting drug handling, and the practice originated partly from observing that BSA scaling allowed dose translation between animal species in early oncology research. The problem is that correlation with drug clearance specifically turns out to be weaker than assumed for many agents. Studies examining the relationship between BSA and pharmacokinetic parameters have frequently found little correlation, meaning that BSA-based dosing does not reliably reduce variation in drug exposure between patients, which was its entire purpose. Despite this, the convention persists because it is deeply embedded in trial protocols, regulatory approvals, and clinical practice, and because alternatives require pharmacokinetic monitoring or genotyping that are not universally available. Some agents have moved away from it: carboplatin is dosed using the Calvert formula based on renal function rather than BSA, which is a genuine improvement because clearance of that drug is closely tied to glomerular filtration. Flat dosing is used for several newer agents including many monoclonal antibodies, where trials found no advantage to weight or BSA scaling. The direction of travel is toward drug-specific dosing strategies rather than a universal BSA convention.

Deciding which formula to use and when it matters

For most clinical purposes the choice between Du Bois, Mosteller, and the others makes little practical difference, since they agree within a few percent for adults of typical build. Mosteller is often preferred in practice for its simplicity and because it performs comparably. Where the choice matters more is at the extremes of body size, in paediatrics, and in obesity, and institutional protocols generally specify which formula to use precisely so that dosing is consistent across a service. Anyone using BSA clinically should follow their institution's convention rather than picking one. For non-dosing uses the stakes are lower: cardiac index, which divides cardiac output by BSA, allows comparison across body sizes, and indexed measures are standard in echocardiography and haemodynamic monitoring. Burn assessment uses percentage of total body surface area rather than absolute BSA, calculated by rules such as the Wallace rule of nines or the Lund and Browder chart, the latter being more accurate particularly in children where head and limb proportions differ substantially from adults. Renal function is often reported indexed to a standard 1.73 square metres, which is why eGFR values need de-indexing for drug dosing in patients whose size differs substantially from average.

Why BSA scaling appears throughout physiology

The reason BSA keeps appearing is not arbitrary. Across species, metabolic rate scales with body mass raised to a power less than one, an observation formalised as Kleiber's law with an exponent near three-quarters, and surface area scales with mass to the two-thirds power. Both reflect the geometric reality that as an organism gets larger, volume grows faster than surface area, so heat exchange, gas exchange, and nutrient absorption per unit mass decline with size. Physiological variables tied to those exchange processes therefore scale with surface area more closely than with mass, which is why cardiac output, glomerular filtration rate, and resting energy expenditure are all more consistent when indexed to BSA than when expressed per kilogram. This gives BSA a genuine biological basis rather than being a mere convention. The limitation is that drug clearance depends on specific enzyme and transporter activity, renal function, protein binding, and genetics, and these do not necessarily follow the same scaling relationship. A drug cleared primarily by a polymorphic enzyme will vary between patients according to their genotype far more than according to their surface area. This mismatch between a general physiological principle and the specific determinants of individual drug handling is the crux of the dosing debate, and it explains why BSA remains useful for indexing physiological measurements while being questioned for dosing.

Variations: other formulas, indexed measures, and paediatric use

Alternative BSA formulas each have their contexts. Mosteller is favoured for simplicity and is widely used in oncology. Haycock was derived with attention to paediatric applicability. Gehan and George used a larger sample than Du Bois. Boyd and Takahira appear in some settings. In paediatrics, BSA-based dosing is common for several drug classes, and formula choice matters more because errors scale proportionally more in small patients; several paediatric protocols also switch between weight-based and BSA-based dosing above or below certain thresholds. Indexed measures using BSA are standard across cardiology, including cardiac index, stroke volume index, and indexed chamber dimensions in echocardiography, allowing meaningful comparison between patients of different sizes and against reference ranges. Renal function reported as eGFR is indexed to 1.73 square metres by convention, which requires de-indexing when using it for drug dosing in patients whose BSA differs substantially. Lean body weight and adjusted body weight are alternative scalars used for certain drugs where distribution into fat is limited, and choosing the right scalar for a given drug is a recognised part of clinical pharmacology.

Using BSA appropriately

Follow your institution's specified formula if using BSA clinically, since Du Bois, Mosteller, and others diverge more at the extremes of body size and consistency across a service matters more than which one is theoretically best. Recognise that Du Bois derives from a 1916 study of nine subjects and tends to underestimate in obesity relative to more recently derived equations. Be aware that BSA-based chemotherapy dosing is a convention whose relationship with actual drug clearance is weaker than historically assumed, and that guidelines have moved away from capping BSA in patients with obesity following evidence that capping was associated with worse outcomes. Use percentage of total body surface area with an appropriate chart rather than absolute BSA for burn assessment, preferring Lund and Browder in children. And de-index eGFR from the standard 1.73 square metres when using it for drug dosing in patients whose size differs substantially from average.

What people get wrong

• Assuming BSA formulas are interchangeable, when they diverge at the extremes of body size and Du Bois tends to underestimate in obesity relative to newer equations.
• Treating BSA-based dosing as pharmacologically validated, when studies have frequently found weak correlation between BSA and drug clearance for many agents.
• Capping BSA for chemotherapy dosing in patients with obesity, a practice guidelines have moved away from following evidence it was associated with worse outcomes.
• Using eGFR indexed to 1.73 square metres directly for drug dosing, when it needs de-indexing for patients whose body size differs substantially from average.

Where the math comes from

Du Bois formula: BSA in m² = 0.007184 × Weight in kg^0.425 × Height in cm^0.725. Imperial inputs are converted by dividing pounds by 2.20462 and multiplying inches by 2.54. Alternative formulas including Mosteller, which computes the square root of height in cm multiplied by weight in kg divided by 3600, generally agree within a few percent for adults of typical build and diverge more at the extremes.

Questions and answers

Related calculators

Migraine Tracker · Diabetic Carb · Supplement Dosage by Weight · Posture Break · Period